Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jandreau
T Bever

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2003
Hematopoietic progenitors express neural genesJames Goolsby, Marie C Marty, Dafna Heletz, et al.
Journal of Rehabilitation Research and Development|April 6, 2006
Short-duration robotic therapy in stroke patients with severe upper-limb motor impairmentMargaret A Finley, Susan E Fasoli, Laura Dipietro, et al.
Journal of Neuroimmunology|April 14, 2009
Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicleTapas K Makar, Christopher T Bever, Ishwar S Singh, et al.
Medical Care|September 14, 2019
Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to ApplicationAmy M Kilbourne, Melissa Z Braganza, Nicholas W Bowersox, et al.
Neurology|December 1, 1996
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trialC T Bever, P A Anderson, J Leslie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2013
Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targetsVamshi K Nimmagadda, Christopher T Bever, Narasimha R Vattikunta, et al.
Neurology|November 25, 2015
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyJodie K Haselkorn, Christina Hughes, Alex Rae-Grant, et al.
Journal of Neuroinflammation|November 20, 2015
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitisTapas K Makar, Volodymyr Gerzanich, Vamshi K C Nimmagadda, et al.
Autoimmune Diseases|May 2, 2012
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation StudyVijayshree Yadav, Dennis N Bourdette, James D Bowen, et al.
Journal of Neuroimmunology|May 13, 2008
Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitisTapas K Makar, David Trisler, Christopher T Bever, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2003
Hematopoietic progenitors express neural genesJames Goolsby, Marie C Marty, Dafna Heletz, et al.
Journal of Rehabilitation Research and Development|April 6, 2006
Short-duration robotic therapy in stroke patients with severe upper-limb motor impairmentMargaret A Finley, Susan E Fasoli, Laura Dipietro, et al.
Journal of Neuroimmunology|April 14, 2009
Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicleTapas K Makar, Christopher T Bever, Ishwar S Singh, et al.
Medical Care|September 14, 2019
Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to ApplicationAmy M Kilbourne, Melissa Z Braganza, Nicholas W Bowersox, et al.
Neurology|December 1, 1996
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trialC T Bever, P A Anderson, J Leslie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2013
Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targetsVamshi K Nimmagadda, Christopher T Bever, Narasimha R Vattikunta, et al.
Neurology|November 25, 2015
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyJodie K Haselkorn, Christina Hughes, Alex Rae-Grant, et al.
Journal of Neuroinflammation|November 20, 2015
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitisTapas K Makar, Volodymyr Gerzanich, Vamshi K C Nimmagadda, et al.
Autoimmune Diseases|May 2, 2012
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation StudyVijayshree Yadav, Dennis N Bourdette, James D Bowen, et al.
Journal of Neuroimmunology|May 13, 2008
Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitisTapas K Makar, David Trisler, Christopher T Bever, et al.
Pageof 10